• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低分子量肝素治疗监测:三种发色底物测定法与Heptest凝血测定法的比较

Monitoring therapy with LMW heparin: a comparison of three chromogenic substrate assays and the Heptest clotting assay.

作者信息

Abildgaard U, Norrheim L, Larsen A E, Nesvold A, Sandset P M, Odegaard O R

机构信息

Department of Medicine with Haematological Research Laboratory, Oslo, Norway.

出版信息

Haemostasis. 1990;20(4):193-203. doi: 10.1159/000216127.

DOI:10.1159/000216127
PMID:2173672
Abstract

Three LMW heparins (LMWH), one unfractionated heparin (UH), and international standards of LMWH and UH were compared in three chromogenic substrate (CS) assays and the 'Heptest' clotting assay. With a two-stage CS assay, linear standard curves were obtained in the 0.1-1.0 U/ml range, nearly coinciding for all preparations. With the one-stage CS assays, standard curves were curvilinear and similar for UH and the LMWH groups. In the Heptest assay, standard curves were linear for UH but not for LMWH. Mean recovery of LMWH, added to patients' plasma samples was 70-98% for the four assays. Variation between individual recoveries was much greater with Heptest (coefficient of variation (CV) 35-44%) than with one-stage CS assays (CV 14-21%) or two-stage CS assays (CV 7-8%). For monitoring LMW heparin therapy, CS assays seem preferable to Heptest. The two-stage CS assay had superior accuracy, but the one-stage CS assays were easier to perform.

摘要

在三种显色底物(CS)测定法和“Heptest”凝血测定法中,对三种低分子量肝素(LMWH)、一种普通肝素(UH)以及LMWH和UH的国际标准品进行了比较。在两阶段CS测定法中,在0.1 - 1.0 U/ml范围内获得了线性标准曲线,所有制剂的曲线几乎重合。在单阶段CS测定法中,标准曲线呈曲线状,UH组和LMWH组相似。在“Heptest”测定法中,UH的标准曲线是线性的,但LMWH不是。添加到患者血浆样本中的LMWH在四种测定法中的平均回收率为70 - 98%。与单阶段CS测定法(变异系数(CV)14 - 21%)或两阶段CS测定法(CV 7 - 8%)相比,Heptest法中个体回收率之间的差异要大得多(CV 35 - 44%)。对于监测低分子量肝素治疗,CS测定法似乎比“Heptest”更可取。两阶段CS测定法具有更高的准确性,但单阶段CS测定法操作更简便。

相似文献

1
Monitoring therapy with LMW heparin: a comparison of three chromogenic substrate assays and the Heptest clotting assay.低分子量肝素治疗监测:三种发色底物测定法与Heptest凝血测定法的比较
Haemostasis. 1990;20(4):193-203. doi: 10.1159/000216127.
2
Monitoring of heparins in haemodialysis using an anti-factor-Xa-specific whole-blood clotting assay.使用抗Xa因子特异性全血凝血测定法监测血液透析中的肝素。
Nephrol Dial Transplant. 1995;10(2):217-22.
3
[Monitoring of plasma concentration of low molecular weight heparin--comparative evaluation with chromogenic and clotting assays].
Rinsho Byori. 1999 Nov;47(11):1046-51.
4
Heptest-STAT, a new assay for monitoring of low-molecular-weight heparins, is not influenced by pregnancy-related changes of blood plasma.Heptest-STAT,一种用于监测低分子量肝素的新检测方法,不受与妊娠相关的血浆变化的影响。
Thromb Haemost. 2009 Nov;102(5):1001-6. doi: 10.1160/TH08-09-0560.
5
Comparative study on a new one-stage clotting assay for heparin and its low molecular weight derivatives.肝素及其低分子量衍生物新型一步凝血测定法的比较研究
Haemostasis. 1989;19(1):13-20. doi: 10.1159/000215883.
6
Effect of tissue factor pathway inhibitor (TFPI) in the HEPTEST assay and in an amidolytic anti factor Xa assay for LMW heparin.组织因子途径抑制剂(TFPI)在用于低分子量肝素的HEPTEST检测和酰胺水解抗Xa因子检测中的作用。
Thromb Haemost. 1992 Sep 7;68(3):310-4.
7
Monitoring of heparin and low molecular weight heparin with capillary and venous whole blood.
Thromb Haemost. 1988 Dec 22;60(3):377-81.
8
Laboratory monitoring of a low molecular weight heparin (enoxaparin) with a new clotting test (Heptest).使用新型凝血试验(七因子检测)对低分子量肝素(依诺肝素)进行实验室监测。
Haemostasis. 1987;17(3):127-33. doi: 10.1159/000215570.
9
HEPTEST: a suitable method for monitoring heparin during pregnancy.HEPTEST:一种监测孕期肝素的合适方法。
Clin Lab Haematol. 1999 Jun;21(3):193-9. doi: 10.1046/j.1365-2257.1999.00208.x.
10
Clinical evaluation of a new one-stage clotting assay for heparin and low molecular weight heparins.一种新型肝素和低分子肝素一步凝血检测法的临床评估
J Mal Vasc. 1987;12 Suppl B:68-70.

引用本文的文献

1
Tinzaparin. A review of its pharmacology and clinical potential in the prevention and treatment of thromboembolic disorders.
Drugs. 1994 Oct;48(4):638-60. doi: 10.2165/00003495-199448040-00010.